021-51111890
购物车（）
sales@molnova.cn
Navuridine
CAS No. 84472-85-5
Navuridine ( AZdU | AzUrd | CS-87 | 3'-Azido-2',3'-dideoxyuridine | CS 87 | AZddU )
产品货号. M27413 CAS No. 84472-85-5
Navuridine 是一种口服活性 HIV 逆转录酶抑制剂，半衰期相对较短。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥312 | 有现货 |
|
| 10MG | ￥509 | 有现货 |
|
| 25MG | ￥1004 | 有现货 |
|
| 50MG | ￥1553 | 有现货 |
|
| 100MG | ￥2268 | 有现货 |
|
| 200MG | ￥3321 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥319 | 有现货 |
|
生物学信息
-
产品名称Navuridine
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Navuridine 是一种口服活性 HIV 逆转录酶抑制剂，半衰期相对较短。
-
产品描述Navuridine is an oral active inhibitor of HIV reverse transcriptase with a relatively short half-life.
-
体外实验——
-
体内实验Pharmacokinetic Parameters of 3′-Azido-2′,3′-dideoxyuridine in male Sprague-Dawley rats. Animal Model:Adult male Sprague-Dawley rats (300-400 g)Dosage:25, 100 mg/kg Administration:Intravenous bolus injection or oral gavage (Pharmacokinetic Analysis)Result:The oral bioavailability estimates of 3′-Azido-2′,3′-dideoxyuridine at doses of 25 and 100 mg/kg averaged 53%.
-
同义词AZdU | AzUrd | CS-87 | 3'-Azido-2',3'-dideoxyuridine | CS 87 | AZddU
-
通路Microbiology/Virology
-
靶点HIV
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number84472-85-5
-
分子量253.218
-
分子式C9H11N5O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 250 mg/mL (987.32 mM)
-
SMILESOC[C@H]1O[C@H](C[C@@H]1N=[N+]=[N-])n1ccc(=O)[nH]c1=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Fang Liu, et al. N-3-oxo-octanoyl-homoserine lactone-mediated priming of resistance to Pseudomonas syringae requires the salicylic acid signaling pathway in Arabidopsis thaliana. BMC Plant Biol. 2020 Jan 28;20(1):38.
产品手册
关联产品
-
L 756423
L 756423 (L756423) is a novel potent and selective and competitive HIV protease inhibitor with a Ki value of 0.049 nM for HIV-1 PR.L 756423 blocks the spread of HIV(IIIb)-infected MT25 lymphocytes at 0.50-0.1 nM and can be used for the study of Acquired Immunodeficiency Syndrome (AIDS).
-
ALW-II-41-27
ALW-II-41-27 是一种 Eph 受体酪氨酸激酶抑制剂，用于癌症治疗。
-
PDDC inhibitor
PDDC inhibitor (Phenyl (R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b]pyridazin-8-yl)pyrrolidin-3-yl)carbamate) is a selective and highly potent nSMase2 inhibitor.
